Abstract
Objective
Panax notoginseng (P.notoginseng) has been used traditionally to treat traumatic injuries. Ginsenoside Rb1, a key active ingredient derived from P.notoginseng, has received a lot of interest due to its anti-inflammatory, bacteriostatic, and growth-promoting effects on cells. The therapeutic benefits of ginsenoside Rb1 on burn wounds in STZ-induced diabetic rats, as well as the probable underlying processes, were investigated in this work.
Materials and Methods
The skin wound healing effect of ginsenoside Rb1 (0.25 and 0.5% w/w) in a rat model of burn wounds in diabetic rats was observed at various time points after treatment. On days 5 and 19 following treatment, immunohistochemistry and Western blot analysis for Interleukin 1 beta (IL-1β), Tumour necrosis factor-α (TNF-α), Cluster of Differentiation 68 (CD68) and Cluster of Differentiation 163 (CD163) of biological tissues were done. The macroscopic observation was used to track the healing of skin wounds at various periods. The protein expression of CD68 and CD163, which serve as M1 and M2 macrophage markers, was examined in detail. More notably, the ability of ginsenoside Rb1 to alter inflammatory markers (IL-6) and anti-inflammatory markers (IL-10), influence on hydroxyproline and hexosamine was observed.
Results
As indicated by increased CD163 (M2) and reduced CD68 (M1) on day 5, ginsenoside Rb1 effectively flips the M1 to M2 phenotypic transition at the right time to improve burn wound healing in diabetic rats. Ginsenoside Rb1 (0.5 % w/w) treatment showed higher tensile strength, anti-inflammatory properties, antioxidant properties, increased tissue hexosamine and hydroxyproline levels. Skin tissue morphology was significantly improved following 19 days of ginsenoside Rb1 (0.5% w/w) therapy, according to hematoxylin-eosin and Masson’s trichrome staining. Furthermore, Ginsenoside Rb1 (0.5% w/w) favoured the inflammatory phase of burn wound healing (IL-6), assisted the proliferation process (IL-10) and had considerably lower expression of IL-1β and TNF-α on the later stage of wound healing.
Conclusion
Overall, the data showed that ginsenoside Rb1 (0.5 % w/w) accelerates burn wound healing in diabetic rats through a mechanism that may be linked to the M1 to M2 phenotypic shift.
Similar content being viewed by others
Data Availability
None.
Abbreviations
- SSD :
-
Silver sulfadiazine
- STZ :
-
Streptozotocin
- LPO :
-
Lipid peroxidation
- GSH :
-
Glutathione
- SOD :
-
Superoxide dismutase
- CAT :
-
Catalase
- VEGF :
-
Vascular endothelial growth factor
- PPAR :
-
Proliferator-activated receptor
References
Bairy, K.L., Abhinav, R., Satyam, S.M.: Evaluation of burn wound healing activity of topical regular insulin in non-diabetic and streptozocin-induced diabeticrats. Int. J. Pharm. Pharm. Sci. 6(8), 127–130 (2014)
Salaran, M., Oryan, A., Nikahval, B., Kamali, A., Ghaemi, M., Abbasi-Teshnizi, F., Azizzadeh, M.: Topical application of Lactobacillus plantarum on burn wound healing in diabetic rats. Iran. J. Vet. Surg. 14(1), 60–72 (2019)
Dolp, R., Rehou, S., Pinto, R., Trister, R., Jeschke, M.G.: The effect of diabetes on burn patients: a retrospective cohort study. Crit. Care 23(1), 28 (2019)
Maghsoudi, H., Aghamohammadzadeh, N., Khalili, N.: Burns in diabetic patients. Int. J. Diabetes Dev. Ctries. 28(1), 19–25 (2018)
Kargozar, S., Mozafari, M., Hamzehlou, S., Baino, F.: Using bioactive glasses in the management of burns. Front Bioeng. Biotechnol. 7, 62 (2019)
Goutos, I., Nicholas, R.S., Pandya, A.A., Ghosh, S.J.: Diabetes mellitus and burns, Part II-outcomes from burn injuries and future directions. Int. J. Burn Trauma 5(1), 13–21 (2015)
Milind, A.M., Sankit, S., Vikrant, R., Pradnya, S., Atul, P.: Comparative study of silver-sulfadiazine-impregnated collagen dressing versus conventional burn dressings in second-degree burns. J. Fam. Med. Prim. Care 8(1), 215–219 (2019)
Liu, X., GanH, Hu, C., Sun, W., Zhu, X., MengZ, Gu, R., Wu, Z., Dou, G.: Silver sulfadiazine nanosuspension-loaded thermosensitive hydrogel as a topical antibacterial agent. Int. J. Nanomed. 14, 289–300 (2018)
Xu, Y., Tan, H.Y., Li, S., Wang, N., Feng, Y.: Panax notoginseng for inflammation-related chronic diseases: a review on the modulations of multiple pathways. Am. J. Chin. Med. 46(5), 971–996 (2018)
Kim, M.K., Kang, H., Baek, C.W., Jung, Y.H., Woo, Y.C., Choi, G.J., Shin, H.Y., Kim, K.S.: Antinociceptive and anti-inflammatory effects of ginsenoside rf in a rat model of incisional pain. J. Ginseng Res. 42(2), 183–191 (2018)
Lee, J.W., Ji, S.H., Choi, B.R., Choi, D.J., Lee, Y.G., Kim, H.G., Kim, G.S., Kim, K., Lee, Y.H., Baek, N.I., Lee, D.Y.: UPLC-QTOF/MS-based metabolomics applied for the quality evaluation of four processed panax ginseng products. Molecules 23(8), 2062 (2018)
Joh, E.H., Lee, I.A., Jung, I.H., Kim, D.H.: Rb1 and its metabolite compound K inhibit IRAK-1 activation–the key step of inflammation. Biochem. Pharmacol. 82(3), 278–286 (2011)
Lu, J.M., Jiang, Jamaluddin, M.S., Liang, Z., Yao, Q., Chen, C.: Rb1 blocks ritonavir-induced oxidative stress and eNOS downregulation through activation of estrogen receptor-beta and upregulation of SOD in human endothelial cells. Int. J. Mol. Sci. 20(2), 294 (2019)
Suntar, I., Akkol, E.K., Senol, F.S., HKeles, I.: Erdogan Orhana, investigating wound healing, tyrosinase inhibitory and antioxidant activities of the ethanol extracts of Salvia cryptantha and Salvia cyanescens using in vivo and in vitro experimental models. J. Ethnopharmacol. 135, 71–77 (2011)
ManimekalaiPichaivel, Krishnaraju, Venkatesan, Kalpana, Krishnaraju, Saravanan, V.S., PremalathaPaulsamy, Divya: Effect of Buchanania Lanzanon wound healing potential in diabetic rats. World J. Pharm. Sci. 9(8), 97–100 (2021)
Moghaddam, Z.P., Zolfaghari, M.R., Ghaemi, E.A., Mazandarani, M., Mansourian, A.R., Taheri, S.A.: Negative performance of root extract of onosmadichroanthumboiss. On the burn wound healing in an animal model. Arch. Clin. Microbial. 2(5), 1–5 (2011)
Kokane, D., More, R., Kale, M., Nehete, M., Mehendale, P., Gadgoli, C.: Evaluation of wound healing activity of root of Mimosa pudica. J. Ethnopharmacol. 124(2), 311–5 (2009)
Suntar, I.P., Akkol, E.K., Yilmazer, D., Baykal, T., Kirmizibekmez, H., Alper, M.: Investigations on the in vivo wound healing potential of Hypericum perforatum L. J. Ethnopharmacol. 127(2), 468–77 (2010)
Ghaisas, M.M., Kshirsagar, S.B., Sahane, R.S.: Evaluation of wound healing activity of ferulic acid in diabetic rats. Int. Wound J. 11(5), 523–32 (2014)
Chen, W.C., Liou, S.S., Tzeng, T.F., Lee, S.L., Liu, I.M.: Wound repair and anti-inflammatory potential of Lonicera japonica in excision wound-induced rats. BMC Complement Altern. Med. 12, 226 (2012)
Li, Juan, Chou, Haiyan, Li, Lei, Li, Hao, Zhengjun Cui: Wound healing activity of neferine in experimental diabetic rats through the inhibition of inflammatory cytokines and nrf-2 pathway. Artif Cells Nanomed. Biotechnol. 48(1), 96–106 (2020)
Knowlin, L., Strassle, P.D., Williams, F.N., Thompson, R., Jones, S., Weber, D.J., van Duin, D., Cairns, B.A., Charles, A.: Burn injury outcomes in patients with pre-existing diabetic mellitus: risk of hospital-acquired infections and inpatient mortality. Burns 44(2), 272–279 (2018)
Maranda, E.L., Rodriguez-Menocal, L., Badiavas, E.V.: Role of mesenchymal stem cells in dermal repair in burns and diabetic wounds. Curr. Stem Cell Res. Ther. 12(1), 61–70 (2017)
Mosser, D.M., Edwards, J.P.: Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8(12), 958–969 (2008)
Kawahira, K., Sumiyoshi, M., Sakanaka, M., Kimura, Y.: Effects of ginsenoside Rb1 at low doses on histamine, substance P, and monocyte chemoattractant protein 1 in the burn wound areas during the process of acute burn wound repair. J. Ethnopharmacol. 117(2), 278–84 (2008)
Hou, J., Kim, S.: Possible role of ginsenoside Rb1 in skin wound healing via regulating senescent skin dermal fibroblast. Biochem. Biophys. Res. Commun. 499(2), 381–388 (2018)
Landén, N.X., Li, D., Ståhle, M.: Transition from inflammation to proliferation: a critical step during wound healing. Cell Mol. Life Sci. 73(20), 3861–3885 (2016)
Mustoe, T.A., O’Shaughnessy, K., Kloeters, O.: Chronic wound pathogenesis and current treatment strategies: a unifying hypothesis. Plast. Reconstr. Surg. 117(7), 35S-41S (2006)
Sen, C.K., Gordillo, G.M., Roy, S., Kirsner, R., Lambert, L., Hunt, T.K., Gottrup, F., Gurtner, G.C., Longaker, M.T.: Human skin wounds: a major and snowballing threat to public health and the economy. Wound Repair Regen. 17(6), 763–771 (2009)
Reinke, J.M., Sorg, H.: Wound repair and regeneration. Eur. Surg. Res. 49(1), 35–43 (2012)
Xue, M., Jackson, C.J.: Extracellular matrix reorganization during wound healing and its impact on abnormal scarring. Adv. Wound Care 4(3), 119–136 (2015)
Brancato, S.K., Albina, J.E.: Wound macrophages as key regulators of repair: origin, phenotype, and function. Am. J. Pathol. 178(1), 19–25 (2011)
Stein, M., Keshav, S., Harris, N., Gordon, S.: Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J. Exp. Med. 176(1), 287–292 (1992)
Mirza, R.E., Fang, M.M., Novak, M.L., Urao, N., Sui, A., Ennis, W.J., Koh, T.J.: Macrophage PPARgamma and impaired wound healing in type 2 diabetes. J. Pathol. 236(4), 433–444 (2015)
Zhang, L., Hu, Q., Jin, H., Yang, Y., Yang, Y., Yang, R., Shen, Z., Chen, P.: Effects of ginsenoside Rb1 on second-degree burn wound healing and FGF-2/PDGF-BB/PDGFR-β pathway modulation. Chin. Med. 16(1), 45 (2021)
Murti, K., Kumar, U.: Enhancement of wound healing with roots of Ficus racemosa L. in albino rats. Asian Pac. J. Trop. Biomed. 2(4), 276–280 (2012)
Roy, P., Amdekar, S., Kumar, A., Singh, R., Sharma, P., Singh, V.: In vivo antioxidative property, antimicrobial and wound healing activity of flower extracts of pyrostegiavenusta (Ker Gawl) Miers. J. Ethnopharmacol. 140(1), 186–92 (2012)
Fusté, N.P., Guasch, M., Guillen, P., Anerillas, C., Cemeli, T., Pedraza, N., Ferrezuelo, F., Encinas, M., Moralejo, M., Garí, E.: Barley β-glucan accelerates wound healing by favoring migration versus proliferation of human dermal fibroblasts. Carbohydr. Polym. 210, 389–398 (2019)
Sun, L., Zhao, Y.: The biological role of dectin-1 in immune response. Int. Rev. Immunol. 26, 349–364 (2007)
Kimura, Y., Sumiyoshi, M., Sakanaka, M.: Effects of ginsenoside Rb1 on skin changes. J. Biomed. Biotechnol. 2012, 946242 (2012)
Daley, J.M., Brancato, S.K., Thomay, A.A., Reichner, J.S., Albina, J.E.: The phenotype of murine wound macrophages. J. Leukoc. Biol. 87, 59–67 (2010)
Sato, Y., Ohshima, T., Kondo, T.: Regulatory role of endogenous interleukin-10 in cutaneous inflammatory response of murine wound healing. Biochem. Biophys. Res. Commun. 265, 194–199 (1999)
Siqueira, M.F., Chehab, L., Krothpali, N., Behl, Y., Yang, J., Braasch, C.: Impaired wound healing in mouse models of diabetes is mediated by TNF-α dysregulation and associated with enhanced activation of forkhead box O1 (FOXO1). Diabetologia. 53, 378–388 (2010)
Mikhal’chik, E.V., Anurov, M.V., Titkova, S.M., Miroshnikova, E.A., Lukasheva, E.V., Deeva, I.B.: Activity of antioxidant enzymes in the skin during surgical wounds. Bull. Exp. Biol. Med. 142(6), 667–9 (2006)
Weindl, G., Schaller, M., Schafer-Korting, M., Korting, H.C.: Hyaluronic acid in the treatment and prevention of skin diseases: molecular biological, pharmaceutical and clinical aspects. Skin Pharmacol. Physiol. 17(5), 207–13 (2004)
Barua, C.C., Talukdar, A., Begum, S.A., Pathak, D.C., Sarma, D.K., Borah, R.S., Gupta, A.: In vivo wound-healing efficacy and antioxidant activity of Achyranthes aspera in experimental burns. Pharm. Biol. 50(7), 892–9 (2012)
Acknowledgements
The authors extend their sincere appreciation to the Deanship of Scientific Research at King Khalid University for funding support for this review through the Large Research Group Project under Grant Number “RGP 2/89/43”.
Funding
This research was funded by the Deanship of Scientific Research at King Khalid University; Grant number “RGP 2/89/43”.
Author information
Authors and Affiliations
Contributions
KV, YA, and YIA and designed research, conducted experiments, and KP, JMMM, and DS analyzed data and wrote the manuscript, RV, NAK, KV, PP, and KK supervision of the work. All authors read and approved the manuscript.
Corresponding author
Ethics declarations
Competing interests
Author declare that there is no potential conflict of interest in this paper.
Ethical Approval
The Institutional Animal Ethics Committee (IAEC) of Erode College of Pharmacy, Erode, Tamilnadu, India (565/02/CA/18/CPCSEA) approved all experimental procedures. Experiments were carried out as per the guidelines for laboratory animal care and use.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Venkatesan, K., Alghazwani, Y., Sivadasan, D. et al. Effects of Bioactive Compound, Ginsenoside Rb1 on Burn Wounds Healing in Diabetic Rats: Influencing M1 to M2 Phenotypic Trans. Waste Biomass Valor 15, 153–162 (2024). https://doi.org/10.1007/s12649-023-02147-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12649-023-02147-y